Global Antiemetics Market to Reach USD 11.20 B by 2030 at ~6% CAGR

◉ Global Antiemetics Market Forecast to Reach USD 11.20 B by 2030, Expanding at ~6.0% CAGR
According to a recent Grand View Research report, the global Antiemetics drugs market-used primarily for nausea and vomiting-is projected to grow from approximately USD 7.90 billion in 2024 to around USD 11.20 billion by 2030, representing a CAGR of about 5.98% over the forecast period .

Download your sample copy of this report today!https://www.maximizemarketresearch.com/request-sample/126745/
◉ Market Overview & Growth Drivers
2024 value: ~USD 7.90 B → 2030 projected value: USD 11.20 B (CAGR ~6.0%)

Primary applications driving demand include chemotherapy-induced nausea (~45.7% share in 2023) and postoperative nausea & vomiting (fastest-growing)

Leading drug classes: Serotonin‐receptor antagonists remain dominant (~30% market share), followed by dopamine‐ and neurokinin-receptor antagonists

◉ Competitive Landscape
Notable players include Pfizer, Cipla, Merck KGaA, Johnson & Johnson, GSK, Astellas, Eagle Pharmaceuticals, Baxter, and Viatris Many are driving innovation through FDA approvals like AKYNZEO (Helsinn/Astellas) and expanding delivery formats for chemotherapy and postoperative care

◉ Regional Demand & Fastest Growth
Region 2023 Value (USD) CAGR (2024-30) Remarks
North America ~36.5% share ~4.8% Market leader driven by cancer care volume and insurer coverage
Europe Not specified Moderate Mature market with stable demand
Asia-Pacific USD 1.58 B 8.3% Fastest‐growing; dominated by serotonin antagonists; India fastest-growing APAC market

India: USD 337.7 M → USD 630.7 M by 2030 at 9.3% CAGR

China: USD 400.1 M → USD 722.0 M by 2030 at 8.8% CAGR

Secure your sample copy of this report immediately!https://www.maximizemarketresearch.com/request-sample/126745/
◉ Country-Specific Insights
Opportunity Growth in Vietnam
Vietnam is expanding antiemetic adoption in oncology and postoperative care as hospital capacity grows and cancer treatment access improves.

Trends in Thailand
Thailand is introducing newer antiemetics-such as NK1 and neurokinin antagonists-into public hospital formularies to reduce PONV and costs.

Growth in Japan Consolidation
Japan is leveraging domestic and global portfolios (e.g., from Pfizer, Merck) to adopt serotonin antagonists and NK1 drugs post-approval, aligning with chemotherapy protocols.

Updation in South Korea
South Korea is upgrading hospital antiemetic formularies with long-acting injections and generics, guided by updated regulatory approvals and coverage schemes.

Benchmarking in Singapore Opportunity
Singapore's healthcare system is piloting best-in-class antiemetic protocols-such as combination therapies-for oncology and day-surgery centers at tertiary hospitals.

Consolidation Trends in the United States
US-based pharmaceutical firms continue acquiring oncology and supportive care pipelines to bundle antiemetics with chemotherapy assets and address formulary competition.

Growth in China
Chinese clinical oncology programs and post-surgical care increasingly use branded and generic antiemetics; multinational firms are partnering with local companies to scale access.

Compliance & Opportunity in Europe
Europe's regulatory environment-via EMA and national agencies-supports safe, reimbursable NK1 and 5-HT3 medications; emphasis is on demonstrating tolerability and cost-effectiveness

To learn more about the findings of this research, please check:https://www.maximizemarketresearch.com/market-report/antiemetics-market/126745/
◉ Antiemetics Market Segment Analysis:
by Type
5-HT3 receptor antagonists
Dopamine antagonists
NK1 receptor antagonist
Antihistamines
Cannabinoids
Benzodiazepines
Anticholinergics

by Application
Chemotherapy
Motion sickness
Gastroenteritis
General anesthetics
Opioid analgesics

◉ Mergers & Acquisitions
Strategic investments by key players in combination NK1/5-HT3 products to solidify position for chemotherapy-induced nausea solutions.

Companies are expanding through licensing agreements (e.g., AKYNZEO by Helsinn/Astellas, Glenmark I.V. pyl formulations in India)

◉ Key Recent Developments
AKYNZEO I.V. launch in India (Jan 2023) to support chemotherapy regimens

FDA approvals for newer agents, including fosnetupitant and post-op doses like BARHEMSYS, enhancing postoperative and chemo care

Studies continue to highlight effectiveness of ondansetron and related drugs in alcohol-use disorder and food-poisoning settings

◉ Get Market Research Latest Trends
Global Expression Vector Market https://www.maximizemarketresearch.com/market-report/global-expression-vector-market/115976/

Global Neurostimulation device Market https://www.maximizemarketresearch.com/market-report/global-neurostimulation-devices-market/10802/

Australia Medical and Diagnostic Laboratory Service Market https://www.maximizemarketresearch.com/market-report/australia-medical-and-diagnostic-laboratory-service-market/225756/

Global Pancreatic Cancer Market https://www.maximizemarketresearch.com/market-report/global-pancreatic-cancer-market-overview/85124/

Rabies Diagnostics Market https://www.maximizemarketresearch.com/market-report/rabies-diagnostics-market/106122/

Global Atherosclerosis Drug Market https://www.maximizemarketresearch.com/market-report/global-atherosclerosis-drug-market/35920/

Global Pacemakers and Cardioverter Defibrillators market https://www.maximizemarketresearch.com/market-report/global-pacemakers-and-cardioverter-defibrillators-market/81483/

GlobalRemdesivir Market https://www.maximizemarketresearch.com/market-report/global-remdesivir-market/98790/

Global Acromegaly and Gigantism Treatment market https://www.maximizemarketresearch.com/market-report/global-acromegaly-and-gigantism-treatment-market/82292/

Global Genital Herpes Treatment Market https://www.maximizemarketresearch.com/market-report/global-genital-herpes-treatment-market/121336/

Global Cell Counting Market https://www.maximizemarketresearch.com/market-report/global-cell-counting-market/93226/

Global Home Infusion Therapy Market https://www.maximizemarketresearch.com/market-report/global-home-infusion-therapy-market/69992/

Bone Mineral Testing Market https://www.maximizemarketresearch.com/market-report/bone-mineral-testing-market/215843/

Germany Bioinformatics Market https://www.maximizemarketresearch.com/market-report/germany-bioinformatics-market/225347/

◉ Contact Maximize Market Research:

3rd Floor, Navale IT Park, Phase 2

Pune Banglore Highway, Narhe,

Pune, Maharashtra 411041, India

sales@maximizemarketresearch.com

+91 96071 95908, +91 9607365656

◉ About Maximize Market Research:

Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.

This release was published on openPR.